Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Nanomed Line on the Horizon

04.09.2013
On the 1-2 October leading industrial and academic experts, national authorities, and European Commission representatives will meet for the 2013 European Technology Platform on Nanomedicine (ETPN) Annual Event and General Assembly.

Within the two days leading experts and specialists from all over Europe will discuss the implementation of recommendations identified by the nanomedicine community that will shape the future of the sector in Europe.

The event takes place in Grenoble, France and is organised by CEA-Leti, a leading French research and technology organisation focused on nanotechnologies and their applications in healthcare.

The event aims to provide further details on the ETPN’s recommendations for nanomedicine under the upcoming Research Framework Programme Horizon 2020, the EU's main instrument for research funding in Europe, launching from 2014-2020.

Patrick Boisseau, chairman of the ETPN, said: “The first line has been crossed with the official renewal of the ETPN as a European Technology Platform, which represents an increasingly key element in the European innovation ecosystem and a main bridge between the community and the European Commission that is needed to implement Horizon 2020.”

He added, “We look forward to welcoming all European stakeholders involved in the nanomedicine field during the ETPN GA at CEA-Leti. Organising our annual event at this widely recognised scientific location will bring the ETPN even closer to the nanomedicine community and will provide participants with the opportunity to visit state-of-the-art facilities on site.”

The event focus on establishing the ETPN’s new action plan with a strong attention on strengthening industry engagement and extending the platform’s community as nanomedical R&D is expected to progress in the upcoming years from the pre-clinical to the clinical testing stage. Furthermore, future milestones will be set for the implementation of the recently released White Paper’s concept elaborated by the NANOMED2020 European consortium to drive innovation across Europe in nanomedicine. The White Paper “Contribution of Nanomedicine to Horizon 2020” can be downloaded on the ETPN website: http://www.etp-nanomedicine.eu/etpn-white-paper-2013.

To support and manage the translation of excellent research into innovative medical products in areas of unmet medical need efficiently, the nanomedicine community strives to set up a Translation Hub as an umbrella of dedicated new infrastructures. Notably, this includes a certain Translational Advisory Board to select, guide, and push forward the top applicable concepts: A novel funding instrument for SMEs, and an EU-NCL infrastructure with the strong involvement of its U.S. counterpart, the Nanotechnology Characterization Laboratory (US-NCL) in Frederick, Maryland.

On October 1, following keynote openings from high-level representatives of the French government and the European Commission, selected experts and leading industry specialists will introduce the latest issues evolving around the nanomedicine ecosystem and value chain.

The ETPN GA preliminary programme and online registration form are available on the ETPN Website: http://www.etp-nanomedicine.eu/ga2013.

About ETPN
The European Technology Platform Nanomedicine was established in 2005 as a joint venture of the European Commission and CEOs of large industrial companies, SMEs and academic research institutions to investigate and advance joint activities in the area of nanotechnology in medicine. Since 2005 the ETPN published a number of strategic documents outlining the needs and roadmaps for nanomedicine research in Europe. The ETPN contributed to set up numerous European funded projects providing a first impression of the conditions for a suitable social and economic environment and the structural requirements for an efficient translation of R&D results into innovative nanomedicine. The ETPN supports its members in coordinating their joint research efforts and improving communication amongst the members as well as towards the European Commission and the European Member States.
For more information, visit http://www.etp-nanomedicine.eu.
The renewed list of recognised ETPs is publically available on the European Commission's ETP website: http://cordis.europa.eu/technology-platforms/individual_en.html.
About CEA-Leti
Leti is an institute of CEA, a French research-and-technology organisation with activities in energy, IT, healthcare, defence and security. Leti is focused on creating value and innovation through technology transfer to its industrial partners. It specialises in nanotechnologies and their applications, from wireless devices and systems, to biology, healthcare and photonics. NEMS and MEMS are at the core of its activities. An anchor of the MINATEC campus, CEA-Leti operates 8,000-m² of state-of-the-art clean room space on 200mm and 300mm wafer platforms. It employs 1,700 scientists and engineers including 320 Ph.D. students and 200 assignees from partner companies. CEA-Leti owns more than 2,200 patent families. For more information, visit http://www.leti.fr.
About NANOMED2020
NANOMED2020 is a Coordination and Support Action under the FP7-Health aiming at delivering concrete recommendations to the European Commission to push forward the field of nanomedicine under Horizon 2020. Amongst other activities, NANOMED2020 is focusing on 1) federating the nanomedicine community and establishing a European landscape via mapping all relevant actors, projects and infrastructures and 2) identifying the key bottlenecks of the value chain to focus on to leverage the translational possibilities of the development process and to bring in the end more products onto the market. This project involves seven partners across Europe including the ETPN Secretariat, the CLINAM foundation (Switzerland), the National Institute of Health Carlos III (Spain), Bioanalytik-muenster e.V (Germany), Nanobiotix SA (France), the Fondazione Don Carlo Gnocchi ONLUS (Italy), and SINTEF (Norway).
Press contacts
ETPN | Olivier Fontaine and Nicolas Gouze secretariat@etp-nanomedicine.eu
CEA-Leti +33 4 38 78 02 26 pierre-damien.berger@cea.fr
CEA Com Agency +33 1 70 29 08 59 sldampoux@mahoneylyle.com

Wiebke Ehret | idw
Further information:
http://www.vdivde-it.de

More articles from Event News:

nachricht Expert meeting “Health Business Connect” will connect international medical technology companies
20.04.2017 | IVAM Fachverband für Mikrotechnik

nachricht Wenn der Computer das Gehirn austrickst
18.04.2017 | Hochschule für Gestaltung Schwäbisch Gmünd

All articles from Event News >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Deep inside Galaxy M87

The nearby, giant radio galaxy M87 hosts a supermassive black hole (BH) and is well-known for its bright jet dominating the spectrum over ten orders of magnitude in frequency. Due to its proximity, jet prominence, and the large black hole mass, M87 is the best laboratory for investigating the formation, acceleration, and collimation of relativistic jets. A research team led by Silke Britzen from the Max Planck Institute for Radio Astronomy in Bonn, Germany, has found strong indication for turbulent processes connecting the accretion disk and the jet of that galaxy providing insights into the longstanding problem of the origin of astrophysical jets.

Supermassive black holes form some of the most enigmatic phenomena in astrophysics. Their enormous energy output is supposed to be generated by the...

Im Focus: A Quantum Low Pass for Photons

Physicists in Garching observe novel quantum effect that limits the number of emitted photons.

The probability to find a certain number of photons inside a laser pulse usually corresponds to a classical distribution of independent events, the so-called...

Im Focus: Microprocessors based on a layer of just three atoms

Microprocessors based on atomically thin materials hold the promise of the evolution of traditional processors as well as new applications in the field of flexible electronics. Now, a TU Wien research team led by Thomas Müller has made a breakthrough in this field as part of an ongoing research project.

Two-dimensional materials, or 2D materials for short, are extremely versatile, although – or often more precisely because – they are made up of just one or a...

Im Focus: Quantum-physical Model System

Computer-assisted methods aid Heidelberg physicists in reproducing experiment with ultracold atoms

Two researchers at Heidelberg University have developed a model system that enables a better understanding of the processes in a quantum-physical experiment...

Im Focus: Glacier bacteria’s contribution to carbon cycling

Glaciers might seem rather inhospitable environments. However, they are home to a diverse and vibrant microbial community. It’s becoming increasingly clear that they play a bigger role in the carbon cycle than previously thought.

A new study, now published in the journal Nature Geoscience, shows how microbial communities in melting glaciers contribute to the Earth’s carbon cycle, a...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Expert meeting “Health Business Connect” will connect international medical technology companies

20.04.2017 | Event News

Wenn der Computer das Gehirn austrickst

18.04.2017 | Event News

7th International Conference on Crystalline Silicon Photovoltaics in Freiburg on April 3-5, 2017

03.04.2017 | Event News

 
Latest News

New quantum liquid crystals may play role in future of computers

21.04.2017 | Physics and Astronomy

A promising target for kidney fibrosis

21.04.2017 | Health and Medicine

Light rays from a supernova bent by the curvature of space-time around a galaxy

21.04.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>